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Abstract
A change in chromosome number, known as aneuploidy, is a common characteristic of cancer. Aneuploidy disrupts gene
expression in human cancer cells and immortalized human epithelial cells, but not in normal human cells. However, the
relationship between aneuploidy and cancer remains unclear. To study the effects of aneuploidy in normal human cells, we
generated artificial cells of human primary fibroblast having three chromosome 8 (trisomy 8 cells) by using microcell-
mediated chromosome transfer technique. In addition to decreased proliferation, the trisomy 8 cells lost contact inhibition
and reproliferated after exhibiting senescence-like characteristics that are typical of transformed cells. Furthermore, the
trisomy 8 cells exhibited chromosome instability, and the overall gene expression profile based on microarray analyses was
significantly different from that of diploid human primary fibroblasts. Our data suggest that aneuploidy, even a single
chromosome gain, can be introduced into normal human cells and causes, in some cases, a partial cancer phenotype due to
a disruption in overall gene expression.
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Introduction
During cell division, errors in chromosomal segregation result in
the loss or gain of chromosomes in daughter cells, which is referred
to as aneuploidy. An extra or missing chromosome, known as
trisomy and monosomy, respectively, is observed in people with
developmental disabilities, mental retardation, and cancer. In
addition, various types of cancer have karyotypes with complex
numerical aberrations [1–3]. Although increasing evidence that
aneuploidy is a hallmark of cancer, the causal relationship between
aneuploidy and tumorigenesis remains unclear.
The addition of a single chromosome has been reported to
have various transcriptional effects in several cell types [4–6]. An
increase in the average transcriptional activity of a trisomic
chromosome has been observed in trisomic primary mouse cells,
human trisomic colorectal cancer cells, immortalized trisomic
mammary epithelial cells, and acute myeloid leukemia (AML)
cells (with an additional chromosome 8; derived from an AML
patient). One chromosome affected not only the gene expression
levels on the trisomic chromosome but also a large number of
genes on other diploid chromosomes [5]. Apoptosis-regulating
genes were significantly down regulated in AML cells containing
an additional chromosome 8 that were derived from an AML
patient [6].
Despite increased information about the characteristics of
aneuploid human cells, the data reported thus far have been
obtained from immortalized or cancer-derived cells. Normal
human cells have a limited life span and ultimately enter a non-
dividing state called senescence [7,8]. It remains unclear whether
aneuploidy renders cells immortal or if immortalization induces
aneuploidy in cells. To determine the role(s) that aneuploidy plays
in human cancer, it will be indispensable to design artificial
aneuploid model cells derived from normal human cells.
Trisomy is a simple model of aneuploidy with the gain of a
single chromosome. Trisomy of chromosome 8 is the most
commonly observed trisomic chromosomal aberration, as has been
demonstrated in fibroblastic/myofibroblastic tumors (Fig. S1) [9–
12]. In this study, we used normal human diploid embryonic cells
(HE35) as a donor for chromosome transfer, and chromosome 8
was chosen as the introduction chromosome. We succeeded in
isolation of multiple clones that chromosome 8 became trisomic
(trisomy 8 cells). All of the trisomy 8 cells expressed transformed
cell-like phenotypes, such as a loss of contact inhibition, regrowth
after senescence, and chromosome instability. The overall gene
expression profile, determined by microarray analysis, was
significantly different from that of the diploid HE35 cells. Our
results suggest that aneuploidy is a key factor in tumorigenesis, as
demonstrated by disrupted gene expression.
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Generation of human primary cells bearing three copies
of chromosome 8 (trisomy 8 cells)
To generate the trisomy 8 cells, we used microcell-mediated
chromosome transfer (MMCT) to introduce an additional
chromosome 8 into HE35 cells of culture passage 7, which is a
line of normal human diploid primary cells [13]. In this study,
inactivated viral envelope proteins of the haemagglutinating virus
of Japan (HVJ-E) were used. We isolated three independent clones
(HE35tri8-1, -2, and -3) in 35-mm diameter dish, and cultured
them by stepwise scale up until reaching confluence in three
diameter 100 mm dishes (P100). Then cells were stocked at a total
population doubling level of 30 (TPDL 30) for subsequent analysis.
To confirm that the extra chromosome was maintained in each
cell clone, we performed Multicolor FISH, which identifies each
chromosome by a unique fluorescent color (Fig. 1). The
proportion of cells with three copies of chromosome 8 was 90%
in HE35tri8-1 and HE35tri8-3 cells and 79% in HE35tri8-2 cells,
indicating that each clone had an additional chromosome 8
(Fig. 1).
Proliferation defects, loss of contact inhibition, and
regrowth in the trisomy 8 cells
Aneuploidy causes a proliferative disadvantage in mouse cells
[4]. To investigate whether this phenotype could be observed in
normal human cells, we examined the proliferative capacity of the
artificial trisomy 8 cells in culture. Three artificial trisomy 8 cells
had decreased proliferation compared to the diploid HE35 cells
(Figs. 2A, S2A–B), indicating that the presence of an additional
chromosome inhibits cell proliferation in culture.
Normal cell growth is arrested when cells contact each other in
culture and in tissues. This phenomenon, known as contact
inhibition, prevents uncontrolled cellular proliferation [14]. In
contrast, transformed cells pile densely upon one another [15].
Growth arrest was observed upon cell contact for the normal
diploid HE35 cells (Fig. 2B). However, the growth of the trisomy 8
cells (HE35tri8-1, -2, and -3) was not arrested when the cells made
contact in vitro, and the cells piled densely on one another (Fig. 2B).
Normal human cells undergo a finite number of cell divisions
and ultimately enter a non-dividing state called senescence,
whereas neither transformed nor cancer cells undergo senescence
when they become immortalized. To understand the effects of a
single chromosome gain on senescence, we investigated whether
the artificial trisomy 8 cells reached senescence and became
immortalized. Three clones of normal diploid HE35 (HE35-1, -2,
and -4) ultimately entered senescence (Figs. 2C, S3). On the other
hand, the trisomy 8 cells (HE35tri8-1, -2, and -3) temporarily
exhibited senescence-like characteristics, but after 4–6 weeks of
this senescence-like phenotype, a small portion of the trisomy 8
cells had regrown and formed colonies (Figs. 2C and 2D, Table 1).
These colonies were made with relatively small sized cells, and the
characteristic of the colony morphology, such as piled-up and
criss-cross, was the same as those of malignant cells (Fig. 2D). The
colony grew up to approximately 5 mm in diameter, but was not
able to finally get infinite growth ability.
DNA damage and chromosomal aberrations
DNA double-strand breaks (DSBs) observed in early tumors
initiate genomic instability that leads to cancer [16]. We examined
whether DNA DSBs occurred in the trisomy 8 cells (HE35tri8-1,
-2, and -3). Previously, both c-H2AX and 53BP1 were shown to
produce foci that co-localized with DSBs [17–20]. There were no
differences in the number of foci containing co-localized c-H2AX
and 53BP1 in the trisomy 8 cells and the diploid HE35 cells
(Figs. 3A, S4, S5).
Micronucleus assays have emerged as the preferred method to
assess chromosome damage because micronuclei provide an index
of both chromosome breakage and non-disjunction. Micronuclei
are the origin of lagging whole chromosomes and acentric
chromosome fragments during anaphase [21]. The micronucleus
frequencies were no difference between the trisomy 8 cells and the
diploid HE35 cells (Fig. 3B).
Chromosome aberrations are distinctive features of tumors [22].
To investigate whether trisomic conditions bring about chromo-
some aberrations, we analyzed metaphase chromosome aberra-
tions. Diplochromosomes (chromosomes that have undergone
DNA replication but have not segregated) were detected only in
the trisomy 8 cells (Table 2, Fig. S6). Chromatid-type aberrations
were observed in both the diploid HE35 cells and the trisomy 8
cells, whereas chromosome-type aberrations were found only in
the trisomy 8 cells (Table 2). Although the trisomy 8 cells tended to
induce both chromosome aberrations and DNA DSBs more than
the diploid HE35 cells, there was not the statistical significance.
Disruption of global gene expression patterns in the
trisomy 8 cells
We compared the gene expression profiles of the trisomy 8 cells
by microarray analysis. A clustering analysis of genes that
exhibited statistically significant changes revealed a pattern that
clearly separated the trisomy 8 cells from the diploid HE35 cells
(Fig. 4A). The complete dataset is available at the NCBI GEO
database (http://www.ncbi.nlm.nih.gov/projects/geo, accession
number GSE28076).
The number of genes expressed on each chromosome was
examined using a genome-wide transcript expression analysis.
Total 127 genes were significantly altered in expression in the
trisomy 8 cells compare with the diploid HE35 cells (Table S1).
72% of genes (91 genes) altered in expression were up regulated
and the rest (36 genes) were down regulated. We did not yet
identify a pathway associated with these genes. The pattern of
genes expressed on each chromosome was similar in three clones
of the trisomy 8 cells (HE35tri8-1, -2, and -3). The level of genes
expressed on trisomic chromosome 8 was increased an average of
115% in each of the trisomy 8 cells compared to those of the
diploid HE35 cells (Fig. 4B). In contrast, the average gene
expression level on the other chromosomes was significantly
decreased (Fig. 4B).
The trisomy 8 cells showed the malignant morphology, which
occurs for a decrease of the cell adhesion ability. Therefore, to
identify significantly deregulated cell adhesion genes that are
involved in the loss of contact inhibition, microarray analyses were
performed. As shown in Fig. 4C, Cell adhesion molecule 1
(CADM1) was dramatically down regulated in the trisomy 8 cells.
Wilms tumor 1 (WT1), a known oncogene, was markedly up
regulated in the trisomy 8 cells (Fig. 4C), but the relationship
between WT1 and the phenomena in the trisomy 8 cells remained
unclear. Although we have also done the pathway analysis,
unfortunately there was no pathway related with 127 genes that
changed more than 10 times.
Discussion
Our analysis of normal human cells containing an additional
chromosome 8 (trisomy 8 cells) revealed that all trisomy 8 cells share
similar characteristics such as altered gene expression, proliferation
defects, loss of contact inhibition, and regrowth after senescence. A
small portion of the trisomy 8 cells regrew and formed colonies after
Trisomy Associated with Transformed Phenotypes
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The trisomy 8 is the most commonly observed chromosome
number aberration in fibroblastic/myofibro- blastic tumors (Fig. S1)
[9–12]. Transformed cells lose contact inhibition [15] and do not
undergo senescence. Our data showed that introducing a
chromosome 8 into the normal diploid cells causes expression of
transformation-associated phenotypes, such as chromosome insta-
bility, and malignant morphological characters. However, all
trisomy 8 cells did not finally immortalize. We previously reported
that human embryonic cells rapidly deplete telomerase activity
associated with the significant shortening of telomeres, and then
reached senescence. However, rodent embryo cells retained
telomerase activity and the long telomeres (19–50 kb) during the
long-term cultures, and cells immortalized. [23,24]. It is likely that
Figure 1. Generation of trisomic human cells of chromosome 8 (trisomy 8 cells). (A) Example of a Multicolor FISH analysis of a metaphase
spread prepared from HE35tri8-1 at TPDL 30. The arrow indicates the transferred chromosome 8 (the yellow arrow is the neomycin-resistant gene in
the transferred chromosome). (B) Chromosome distribution in the trisomy 8 cells.
doi:10.1371/journal.pone.0025319.g001
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telomerase of human cells. However, unfortunately, because cell
number collected from the regrowth colony was too few in the
present study, we could not measure telomerase activity yet.
The number of foci where c-H2AX and 53BP1 co-localized,
and micronucleus were no difference between the trisomy 8 cells
and the diploid HE35 cells (Fig. 3A–B). However, structural
chromosome aberrations were increased in the trisomy 8 cells
(Table 2). The number of foci where c-H2AX and 53BP1 co-
localized and the micronucleus frequencies were indirect method
of DSB observation, whereas structural chromosome aberrations
were direct method. This suggests that the trisomy does not cause
Figure 2. Proliferation defects, loss of contact inhibition, and regrowth in the trisomy 8 cells. (A) Proliferation defects in the artificial
trisomy 8 cells. The diploid HE35 cells (open squares, open triangles, and open circles) and the trisomy 8 cells (solid squares, solid triangles, and solid
circles) were plated and counted daily to detect changes in the cell numbers. (B) Loss of contact inhibition in the trisomy 8 cells (HE35tri8-1 at TPDL
30, HE35-1 at TPDL 30). (C) Cell growth of the cultured diploid HE35 cells and the trisomy 8 cells. (D) A small portion of the trisomy 8 cells regrew and
formed colonies after 4–6 weeks of exhibiting a senescence-like state. (D-a) HE35tri8-1 colony, (D-b) HE35tri8-2 colony, (D-c) HE35tri8-3 colony.
doi:10.1371/journal.pone.0025319.g002
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suggested that DNA DSB is not a cause of becoming trisomy, but
is a result of trisomy.
Diplochromosomes were found only in the trisomy 8 cells,
suggesting that trisomy of chromosome 8 causes production of
tetraploidy. Although chromatid-type aberrations were seen in both
the diploid HE35 cells and the trisomy 8 cells, chromosome-type
aberrations were observed in the trisomy 8 cells and not in the
diploid HE35 cells. Increased chromosome-type aberrations, but
not chromatid-type aberrations, have been associated with an
increased cancer risk [25]. The present results revealed that trisomy
of chromosome 8 causes other numerical and structural chromo-
somal aberrations that contribute to the relationship between
increased chromosome instability and subsequent cancer risk.
Previous reports have shown that the average level of gene
expression on trisomic chromosomes is increased in mouse cells,
human cancer cells, and immortalized human cells compared to
diploid cells [4–6]. Our artificial trisomy cells derived from
primary human cells had greater average gene expression on the
additional chromosome 8 (Fig. 4B). Surprisingly, the average gene
expression level on all non-trisomic chromosomes was all
decreased; moreover, the profile of each clone was similar
(Fig. 4B). Total 127 genes were significantly altered in expression
in the trisomy 8 cells compare with the diploid HE35 cells (Table
S1). However, it is not clear whether this phenomenon is event
that is specific for chromosome 8. The results of our pilot study
show that similar change of gene expression is obtained in trisomy
of chromosome 1, 6 and 7 (data not shown). These results strongly
suggest that gaining even a single chromosome disrupts the
expression levels on the trisomic chromosome as well as on the
other chromosomes.
Each chromosome occupies a non-random and confined space
in the interphase nucleus of higher eukaryotes [26–28]. There is
increasing evidence that the positioning of genomic regions in the
nuclear space is important for gene regulation [29]. One possible
explanation for the general disturbances in the gene expression
levels in the trisomy cells is alterations in chromosomal territory.
CADM1 was markedly down regulated in the trisomy 8 cells.
The tumor suppressor CADM1 is involved in cell adhesion and is
preferentially inactivated in invasive cancers [30–32]. CADM1 is
expressed universally in human tissues and is frequently silenced in
a variety of human carcinomas [33,34]. A recent study further
showed that hypermethylation of the CADM1 promoter induced
gene silencing [33,35–40]. We speculate that a down-regulation of
the CADM1 gene in the trisomy 8 cells results from hypermethy-
lation of the CADM1 promoter region.
In contrast, WT1 was significantly up regulated in the trisomy 8
cells. The WT1 gene was isolated as the gene responsible for a
childhood renal neoplasm, Wilms’ tumor, which is thought to arise
due to the inactivation of both alleles of the WT1 gene located at
chromosome 11p13 [41–43]. The WT1 gene was originally
defined as a tumor suppressor gene [41,44–48], but recent studies
suggest that the WT1 gene is highly expressed in leukemia and
solid tumors and likely plays an oncogenic role in leukemogenesis
and tumorigenesis [49,50]. It is possible that aneuploidy results in
an epigenetic modification of WT1.
Table 1. Frequency of colony formation by regrowth cells after senescence.
Cells TPDL
a Number of regrowth colony per 1.5610
6 inoculated cells
b
HE35-1 44.2 0
HE35-2 39.5 0
HE35-4 36.7 0
HE35tri8-1 51.0 5.062.3
HE35tri8-2 38.6 3.561.9
HE35tri8-3 40.6 1.061.1
aTotal population doubling levels (TPDL) show the number of cell division that cells divided until reaching to senescence.
bFrequency of colony formation by regrowth cells in three P100 dishes after senescence. Briefly, 1.5610
6 cells were inoculated into three P100 dishes. Then, cells were
incubated in a 100% humidified CO2 incubator at 37uC for 6 weeks with medium change every 3 days. Regrowth colonies were counted. Data show the mean 6 S.D. of
six independent experiments.
doi:10.1371/journal.pone.0025319.t001
Figure 3. DNA damage and chromosome aberrations. (A)
Number of c-H2AX and 53BP1 foci in the diploid HE35 cells (HE35-1,
-2, and -4) and the trisomy 8 cells (HE35tri8-1, -2, and -3). (B)
Micronucleus frequency in the diploid HE35 cells and the trisomy 8 cells.
doi:10.1371/journal.pone.0025319.g003
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a single chromosome causes chromosome instability and extensive
disruption of gene expression. Such critical and extensive changes
in gene expression can produce parts of transformation-associated
phenotypes in aneuploid cells.
Materials and Methods
Cells and cell culture
Human embryonic (HE35) cells were obtained from 7- to 8-
week-old human embryos previously described [51]. HE35 cells
were cultured in Eagle’s Minimum Essential Medium (MEM)
supplemented with 10% fetal bovine serum at 37uC with 5% CO2
in a humidified environment. The trisomy 8 cells (HE35tri8-1, -2,
and -3 cells) were cultured in Eagle’s Minimum Essential Medium
(MEM) containing 800 mg/ml G418 supplemented with 10% fetal
bovine serum at 37uC with 5% CO2 in a humidified environment.
Briefly, both the diploid cells derived from HE35 (HE35-1, 2, and
4) and the artificial trisomy 8 cells (HE35tri8-1, -2, and -3) at
TPDL 30 were plated at 5610
5 cells per T75 flask. Subconfluent
cells were trypsinized and counted to determine the number of
cells per T75 flask, and the cells were then replated at 5610
5 cells
per T75 flask. Medium change has done every three days of all
cultures. This process was repeated until there were either
insufficient cells for plating or immortalization (as determined by
increased cell proliferation).
Microcell-mediated chromosome transfer
Donor mouse A9 cells containing human chromosome 8 were
established by Kugoh et al. [52]. A9 cells grown in three T-25
flasks at 7610
5 cells/flask in medium containing 800 mg/ml G418
(Nakarai Tesque, Kyoto, Japan). To generate normal human cells
containing an additional chromosome 8, we used microcell-
mediated chromosome transfer (MMCT) procedure [13]. Briefly,
the cells were incubated with 0.05 mg/ml colcemid in medium plus
20% fetal bovine serum for 48 h (to induce micronucleus
formation), and then centrifuged in the presence of 10 mg/ml
cytochalasin B (Sigma, MO, USA) at 8,000 rpm for 1 h at 34uCt o
isolate the micronuclei. The micronuclei were then purified by
sequentially filtering through sterile filters of pore size 8-, 5-, and 3-
mm. The purified micronuclei were suspended in fusion buffer and
then HVJ-E was added (Genomone-CF; Ishihara Sangyo, Osaka,
Japan) to the recipient cells (HE35 at TPDL7), which were kept on
ice for 5 min, and then incubated at 37uC for 15 min. The
supernatant was aspirated and MEM containing 800 mg/ml of
G418 and 10% FBS was added.
We isolated three independent trisomy 8 cells (HE35tri8-1, -2,
and -3) in 35-mm diameter dish (P35), and cells were cultured with
doing stepwise scale up using P35, 60-mm diameter dish (P60),
and 100-mm diameter dish (P100). Then, cells were cultured until
reaching confluence in three P100 dishes. At this point, because
total cell number in three dishes is approximately 8610
6, cells of
each clone had divided at least 23 times (8610
6<2
23) during
cloning process. Then, cells were stocked in liquid nitrogen until
doing assay. Therefore, cells at 30 TPDL (7PDL+23PDL) were
used for subsequent assay.
Karyotype analysis
To prepare the metaphase chromosome, 5610
5 cells wereseeded
in P100 dishes. After incubating for 48 h, colcemid (Gibco, CA,
USA) was added at a final concentration of 0.06 mg/ml, and the
cells were treated for 2 h. Mitotic cells were collected and treated
with 0.075 M potassium chloride for 25 min at room temperature.
The cells were fixed in Carnoy’s solution(methanol:acetic acid, 3:1)
and spread on glass slides using the air-drying method. After the
cells were stained with a 3% Giemsa solution, the number of
chromosomes with at least 50 metaphases per sample was scored.
Multicolor fluorescence in situ hybridization (M-FISH)
Multicolor FISH was performed according to the manufactur-
er’s protocol (Cambio, Cambridge, UK). A chromosome slide was
aged on a hot plate at 65uC for 90 min, and the samples were
denatured in a solution (70% formamide in 2X SSC) at 65uC for
2 min. After the reaction was quenched in ice-cold 70% ethanol
for 4 min, the slides were dehydrated by washing for 5 min each in
70% ethanol and 100% ethanol and then dried at 37uC. An
aliquot (10 ml) of the M-FISH probes was denatured at 65uC for
10 min and applied to the chromosome slide. Hybridization was
performed at 37uC for 48 h in a humidified atmosphere. After
hybridization, each slide was washed twice for 5 min each in
washing solution (50% formamide in 0.5X SSC) at 45uC, followed
by two incubations of 5 min each in 1X SSC at 45uC. Each slide
was then incubated for 4 min in detergent washing solution
(0.05% detergent DT in 4X SSC) at 45uC. An aliquot (125 ml) of
the detection reagent was applied to the slides, which were then
covered with parafilm and subsequently incubated in a humidified
atmosphere for 20 min at 37uC. After the parafilm was removed,
the slides were washed three times for 4 min in detergent washing
solution at room temperature. Finally, the DNA was stained with
49, 6-diamino-2-phenylindole (DAPI) in antifade solution. Chro-
mosome images were captured and analyzed using the Leica
CW4000 system.
Table 2. Frequency of chromosome aberrations in the trisomy 8 cells.
Cells Ploidy
No. of cells
scored
Chromosome-type aberration
(%)
Chromatid-type aberration
(%) Diplo-chromosome (%)
Gap Break Ring Gap Break SU*
HE35-1 Diploid 50 0 0 0 0 0 0 0
HE35-2 Diploid 50 0 0 0 0 2 0 0
HE35-4 Diploid 50 0 0 0 0 2 0 0
HE35tri8-1 Trisomy 8 50 2 4 2 0 0 0 6
HE35tri8-2 Trisomy 8 50 0 2 4 4 0 0 8
HE35tri8-3 Trisomy 8 50 2 0 0 0 0 2 0
*Sister Union.
doi:10.1371/journal.pone.0025319.t002
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PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e25319Figure 4. Disruption of the global gene expression patterns in the trisomy 8 cells. (A) Clustering analysis of 127 genes that exhibited
statistically significant changes in the trisomy 8 cells (HE35tri8-1, -2, and -3) versus the diploid HE35 cells (HE35-1, -2, and -4). Three independent
experiments were performed for each clone. (B) Average gene expression pattern by chromosome. The average chromosome expression ratios
relative to the same reference RNA pool for each trisomy 8 cells was then normalized to the average of the ratio value for the diploid HE35 cells. (C)
CADM1 (11q23.2) and WT1 (11p13) gene expression in the trisomy 8 cells (HE35tri8-1, -2, and -3) and the diploid HE35 cells (HE35-1, -2, and -4).
doi:10.1371/journal.pone.0025319.g004
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Exponentially growing diploid HE35 cells (HE35-1, -2, and -4) at
TPDL37andthetrisomy8cells(HE35tri8-1,-2,and-3)atTPDL37
were plated at a density of 5610
4 cells in individual wells of multiple
6-well plates. All cells were plated in a final volume of 3 ml of
medium. Cells were incubated in humidified 5% CO2 incubator at
37uC. The medium was replaced with fresh medium every three days
throughout the experiment. Cells were harvested by trypsinization
and cell number was counted by hemocytometer every day.
Senescence-associated b-galactosidase assay
Cells were washed once with Ca
2+-a n dM g
2+-free phosphate-
buffered saline (PBS
2) and fixed in a 0.2% paraformaldehyde solution
containing 0.2% glutaraldehyde for 5 min at room temperature. After
washing with PBS
2,t h ef i x e dc e l l sw e r ei n c u b a t e di nS A - b-gal staining
solution (40 mM citric acid/sodium phosphate, pH 6.0, 5 mM
potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM
NaCl, and 2 mM MgCl2) containing 1 mg/ml 5-bromo-4-chloro-3-
indolylb-D-galactopyranoside (X-gal) to stain senescent cells.
Immunofluorescence detection
Both the diploid HE 35 cell and the trisomy 8 cells at TPDL 37
were fixed in 4% formaldehyde in PBS
2 for 15 min, permeabilized
for 10 min on ice in 0.5% Triton X-100 in PBS
2, and then washed
extensively with PBS
2. Then, the coverslips were incubated with
anti-phosphorylated histone H2AX at serine 139 (Upstate Biotech-
nology, NY, USA) and 53BP1 (Bethyl Laboratory, TX, USA) in
TBS-DT (20 mM Tris-HCl, 137 mM NaCl, pH 7.6, containing
50 mg/ml skim milk and 0.1% Tween-20) for 2 h at 37uC. The
primary antibodies were washed with PBS
2, and Alexa Fluor 488–
labeled anti-mouse IgG antibody and Alexa Fluor 594–labeled anti-
rabbit IgG antibody (Molecular Probes, CA, USA) was added. The
coverslips were incubated for 1 h at 37uC, washed with PBS
2, and
sealed onglassslideswith0.05 mlofPBS
2 containing 10%glycerol.
The cells were examined by fluorescence microscopy.
Micronucleus assay
Cells at TPDL 37 were treated with 2 mg/ml cytochalasin B for
2 4hi naT 2 5f l a s k .T h e yw e r et h e nh a r v e s t e da n dt r e a t e dw i t h3m lo f
hypotonic (0.1 M) KCl for 20 min, and fixed with 3 ml of methanol/
aceticacid(5:1).The cell suspensionswere centrifuged at 1,200 rpmfor
5 min. Then, the cells were suspended in 4 ml methanol/acetic acid
solution and incubated on ice for 5 min. After centrifugation, the
supernatant was removed and a 0.5–1 ml methanol/acetic acid
solution was added to the cells. The cell suspensions were dropped onto
slides and stained with 7.5% Giemsa for 40 min. The number of
micronuclei per 1,000 binucleated cells was counted.
Transcript array and date analysis
RNA was isolated from cells at TPDL 37 using an RNeasy Mini
Kit (Qiagen, Tokyo, Japan). Five hundred nanograms of total RNA
was then reverse-transcribed and labeled with a Quick Amp Labeling
Kit, as recommended by the manufacturer (Agilent Technologies,
CA,USA)andhybridized toHuman WholeGenome Arrays(Agilent
Technologies, CA, USA). Chips were analyzed and the data were
extracted for examination using GeneSpring GX 11.5 Software
(Agilent Technologies, CA, USA). To identify significantly related
genes, GeneSpring GX 11.5 was used to perform a t-test.
Accession number
The microarray data reported herein are available at the NCBI
GEO database (http://www.ncbi.nlm.nih.gov/projects/geo, ac-
cession number GSE28076).
Supporting Information
Figure S1 The distribution of trisomy in fibroblastic/myofibroblas-
tic tumors (all sub types). The Mitelman Database of Chromosome
Aberrations in Cancers was used as a source of the data (http://cgap.
nci.nih.gov/Chromosomes/Mitelman).
(TIF)
Figure S2 The daily behavior of a culture of normal human cells
(diploid HE35-1) and of a culture of the artificial trisomy 8 cells
(HE35tri8-3) in the same region of culture. (A) normal human cells
(diploid HE35-1), (B) artificial trisomy 8 cells (HE35tri8-3).
(TIF)
Figure S3 Senescence-associated b-galactosidase staining was
altered in cultures of the diploid HE35 cells (HE35-1, -2, and -4).
b-galactosidase staining is shown in blue.
(TIF)
Figure S4 The diploid HE35 cells (HE35-1, -2, and -4) were
coimmunostained with anti-c-H2AX and anti-53BP1 antibodies.
(TIF)
Figure S5 The trisomy 8 cells (HE35tri8-1, -2, and -3) were
coimmunostained with anti-c-H2AX and anti-53BP1 antibodies.
(TIF)
Figure S6 Diplochromosomes at metaphase in the trisomy 8 cell
(HE35tri8-1).
(TIF)
Table S1 The gene number that an expression level was
significantly changed by a chromosome 8 introduction.
(TIFF)
Author Contributions
Conceived and designed the experiments: MW HN GK KT KD YS HK
MO. Performed the experiments: MW HN GK KT KD YS HK MO.
Analyzed the data: MW HN GK KT KD YS HK MO. Contributed
reagents/materials/analysis tools: MW HN GK KT KD YS HK MO.
Wrote the paper: MW HN GK KT KD YS HK MO.
References
1. Ganmore I, Smooha G, Izraeli S (2009) Constitutional aneuploidy and cancer
predisposition. Hum Mol Genet 18: R84–93.
2. Weaver BAA, Cleveland DW (2006) Does aneuploidy cause cancer? Current
Opinion in Cell Biology 18: 658–667.
3. Hassold T, Hunt P (2001) To err (meiotically) is human: the genesis of human
aneuploidy. Nat Rev Genet 2: 280–291.
4. Williams BR, Prabhu VR, Hunter KE, Glazier CM, Whittaker CA, et al. (2008)
Aneuploidy Affects Proliferation and Spontaneous Immortalization in Mamma-
lian Cells. Science 322: 703–709.
5. Upender MB, Habermann JK, McShane LM, Korn EL, Barrett JC, et al. (2004)
Chromosome transfer induced aneuploidy results in complex dysregulation of
the cellular transcriptome in immortalized and cancer cells. Cancer Res 64:
6941–6949.
6. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, et al. (2001) Expression
profiling reveals fundamental biological differences in acute myeloid leukemia with
isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A 98: 1124–1129.
7. Shay JW, Wright WE (2000) Hayflick, his limit, and cellular ageing. Nat Rev
Mol Cell Biol 1: 72–76.
8. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell
strains. Exp Cell Res 25: 585–621.
9. Fletcher JA, Naeem R, Xiao S, Corson JM (1995) Chromosome aberrations in
desmoid tumors trisomy 8 may be a predictor of recurrence. Cancer Genetics
and Cytogenetics 79: 139–143.
10. Schofield DE, Fletcher JA, Grier HE, Yunis EJ (1994) Fibrosarcoma in Infants
and Children: Application of New Techniques. The American Journal of
Surgical Pathology 18: 14–24.
Trisomy Associated with Transformed Phenotypes
PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e2531911. Schofield DE, Yunis EJ, Fletcher JA (1993) Chromosome aberrations in
mesoblastic nephroma. Am J Pathol 143: 714–724.
12. Sankary S, Dickman PS, Wiener E, Robichaux W, Swaney WP, et al. (1993)
Consistent numerical chromosome aberrations in congenital fibrosarcoma.
Cancer Genetics and Cytogenetics 65: 152–156.
13. Doherty AM, Fisher EM (2003) Microcell-mediated chromosome transfer
(MMCT): small cells with huge potential. Mamm Genome 14: 583–592.
14. Fagotto F, Gumbiner BM (1996) Cell Contact-Dependent Signaling. Develop-
mental Biology 180: 445–454.
15. Perucho M, Goldfarb M, Shimizu K, Lama C, Fogh J, et al. (1981) Human-
tumor-derived cell lines contain common and different transforming genes. Cell
27: 467–476.
16. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, et al. (2005) DNA damage
response as a candidate anti-cancer barrier in early human tumorigenesis.
Nature 434: 864–870.
17. Fernandez-Capetillo O, Chen H-T, Celeste A, Ward I, Romanienko PJ, et al.
(2002) DNA damage-induced G2-M checkpoint activation by histone H2AX
and 53BP1. Nat Cell Biol 4: 993–997.
18. Rappold I, Iwabuchi K, Date T, Chen J (2001) Tumor Suppressor P53 Binding
Protein 1 (53bp1) Is Involved in DNA Damage–Signaling Pathways. The
Journal of Cell Biology 153: 613–620.
19. Schultz LB, Chehab NH, Malikzay A, Halazonetis TD (2000) p53 binding
protein 1 (53BP1) is an early participant in the cellular response to DNA double-
strand breaks. J Cell Biol 151: 1381–1390.
20. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA
Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139.
Journal of Biological Chemistry 273: 5858–5868.
21. Fenech M (2000) The in vitro micronucleus technique. Mutation Research/
Fundamental and Molecular Mechanisms of Mutagenesis 455: 81–95.
22. Solomon E, Borrow J, Goddard A (1991) Chromosome aberrations and cancer.
Science 254: 1153–1160.
23. Yang Z, Kodama S, Suzuki K, Watanabe M (1998) Telomerase activity,
telomere length, and chromosome aberrations in the extension of life span of
human embryo cells induced by low-dose X-rays. J Radiat Res (Tokyo) 39(1):
35–51.
24. Kodama S, Mori I, Roy K, Yang Z, Suzuki K, Watanabe M (2001) Culture
condition-dependent senescence-like growth arrest and immortalization in
rodent embryo cells. Radiat Res 155(1 Pt 2): 254–262.
25. Boffetta P, van der Hel O, Norppa H, Fabianova E, Fucic A, et al. (2007)
Chromosomal Aberrations and Cancer Risk: Results of a Cohort Study from
Central Europe. American Journal of Epidemiology 165: 36–43.
26. Meaburn KJ, Misteli T (2007) Cell biology: Chromosome territories. Nature
445: 379–381.
27. Lanctot C, Cheutin T, Cremer M, Cavalli G, Cremer T (2007) Dynamic
genome architecture in the nuclear space: regulation of gene expression in three
dimensions. Nat Rev Genet 8: 104–115.
28. Fraser P, Bickmore W (2007) Nuclear organization of the genome and the
potential for gene regulation. Nature 447: 413–417.
29. Gasser SM (2002) Visualizing Chromatin Dynamics in Interphase Nuclei.
Science 296: 1412–1416.
30. Murakami Y (2005) Involvement of a cell adhesion molecule, TSLC1/IGSF4, in
human oncogenesis. Cancer Science 96: 543–552.
31. Goto A, Niki T, Chi-pin L, Matsubara D, Murakami Y, et al. (2005) Loss of
TSLC1 expression in lung adenocarcinoma: Relationships with histological
subtypes, sex and prognostic significance. Cancer Science 96: 480–486.
32. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, et al. (2001)
TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat
Genet 27: 427–430.
33. Mao X, Seidlitz E, Truant R, Hitt M, Ghosh HP (2004) Re-expression of
TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits
tumor growth. Oncogene 23: 5632–5642.
34. Shingai T, Ikeda W, Kakunaga S, Morimoto K, Takekuni K, et al. (2003)
Implications of Nectin-like Molecule-2/IGSF4/RA175/SgIGSF/TSLC1/Syn-
CAM1 in Cell-Cell Adhesion and Transmembrane Protein Localization in
Epithelial Cells. Journal of Biological Chemistry 278: 35421–35427.
35. Sakurai-Yageta M, Masuda M, Tsuboi Y, Ito A, Murakami Y (2009) Tumor
suppressor CADM1 is involved in epithelial cell structure. Biochemical and
Biophysical Research Communications 390: 977–982.
36. Tsujiuchi T, Sugata E, Masaoka T, Onishi M, Fujii H, et al. (2007) Expression
and DNA methylation patterns of Tslc1 and Dal-1 genes in hepatocellular
carcinomas induced by N-nitrosodiethylamine in rats. Cancer Science 98:
943–948.
37. Shimizu K, Onishi M, Sugata E, Fujii H, Honoki K, et al. (2007) Aberrant DNA
methylation of the 59 upstream region of Tslc1 gene in hamster pancreatic
tumors. Biochemical and Biophysical Research Communications 353: 522–526.
38. Heller G, Fong KM, Girard L, Seidl S, End-Pfutzenreuter A, et al. (2005)
Expression and methylation pattern of TSLC1 cascade genes in lung
carcinomas. Oncogene 25: 959–968.
39. Ito T, Shimada Y, Hashimoto Y, Kaganoi J, Kan T, et al. (2003) Involvement of
TSLC1 in Progression of Esophageal Squamous Cell Carcinoma. Cancer
Research 63: 6320–6326.
40. Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, et al. (2003)
Promoter methylation of the TSLC1 gene in advanced lung tumors and various
cancer cell lines. International Journal of Cancer 107: 53–59.
41. Algar EM, Kenney MT, Simms LA, Smith SI, Kida Y, et al. (1995)
Homozygous intragenic deletion in the WT1 gene in a sporadic Wilms’ tumour
associated with high levels of expression of a truncated transcript. Hum Mutat 5:
221–227.
42. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, et al. (1990)
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by
chromosome jumping. Nature 343: 774–778.
43. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, et al. (1990) Isolation and
characterization of a zinc finger polypeptide gene at the human chromosome 11
Wilms’ tumor locus. Cell 60: 509–520.
44. Loeb D, Sukumar S (2002) The Role of WT1 in Oncogenesis: Tumor
Suppressor or Oncogene? International Journal of Hematology 76: 117–126.
45. Little M, Wells C (1997) A clinical overview of WT1 gene mutations. Human
Mutation 9: 209–225.
46. Rauscher F (1993) The WT1 Wilms tumor gene product: a developmentally
regulated transcription factor in the kidney that functions as a tumor suppressor.
The FASEB Journal 7: 896–903.
47. Haber DA, Park S, Maheswaran S, Englert C, Re GG, et al. (1993) WT1-
mediated growth suppression of Wilms tumor cells expressing a WT1 splicing
variant. Science 262: 2057–2059.
48. Coppes M, Campbell C, Williams B (1993) The role of WT1 in Wilms
tumorigenesis. The FASEB Journal 7: 886–895.
49. Huff V (2011) Wilms’ tumours: about tumour suppressor genes, an oncogene
and a chameleon gene. Nat Rev Cancer 11: 111–121.
50. Sugiyama H (2010) WT1 (Wilms’ tumor gene 1): biology and cancer
immunotherapy. Jpn J Clin Oncol 40: 377–387.
51. Suzuki M, Yang Z, Nakano K, Yatagai F, Suzuki K, et al. (1998) Extension of in
vitro life-span of gamma-irradiated human embryo cells accompanied by
chromosome instability. J Radiat Res (Tokyo) 39: 203–213.
52. Kugoh H, Mitsuya K, Meguro M, Shigenami K, Schulz TC, Oshimura (1999)
Mouse A9 cells containing single human chromosomes for analysis of genomic
imprinting. DNA Res 6: 165–172.
Trisomy Associated with Transformed Phenotypes
PLoS ONE | www.plosone.org 9 September 2011 | Volume 6 | Issue 9 | e25319